Year : 2012 | Volume : 11 | Issue : 1 | Page : 1--15
Schistosomiasis ( chemoprophylaxis and treatments)
Magdy I El-Zahar, Somaia El-Karim
Department of Therapeutical Chemistry, National Research Centre, Pharmaceutical and Drug Industries Research Division, Cairo, Egypt
Schistosomiasis is a chronic parasitic disease affecting about 207 million individuals worldwide. It is still a major health problem in many tropical and subtropical countries, as well as for travelers from developed countries. The treatment strategies of schistosomiasis can be divided into two main routes: (a) chemotherapy treatment including trivalent antimony compounds, hycanthone mesylate, niridazole, metrifonate, oxamniquine, oltipraz, artemisinins, albendazole, amoscanate mirazid, and praziquantel; (b) vaccines that may play an important role in the control of schistosomiasis in the future.